20 Dec, EOD - Indian

SENSEX 78041.59 (-1.49)

Nifty 50 23587.5 (-1.52)

Nifty Bank 50759.2 (-1.58)

Nifty IT 43771.05 (-2.63)

Nifty Midcap 100 56906.75 (-2.82)

Nifty Next 50 68702.65 (-2.72)

Nifty Pharma 22501.85 (-0.86)

Nifty Smallcap 100 18714.3 (-2.19)

20 Dec, EOD - Global

NIKKEI 225 38701.9 (-0.29)

HANG SENG 19720.7 (-0.16)

S&P 6008.5 (1.05)

Login/Signup
LOGIN HERE
Cancel

Krishna Institute of Medical Sciences Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543308 | NSE Symbol : KIMS | ISIN : INE967H01025 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
25-Oct-2024 09-Nov-2024 Quarterly Results Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results of the Company for the 02nd quarter and half-year ended September 30 2024. Half-year ended 30 September 2024 together with the Limited Review Reports as reviewed by the Audit Committee. (As Per BSE Announcement dated on 09.11.2024)
25-Jul-2024 07-Aug-2024 Quarterly Results Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve the unaudited (Standalone & Consolidated) financial results of the company for the 01st quarter ended June 30 2024. Financial Results for the 01st Quarter ended 30th June 2024. Outcome of the Board Meeting held on 07th August 2024. (As per BSE Announcement Dated on 07/08/2024)
24-Jun-2024 28-Jun-2024 Stock Split Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2024 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Friday June 28th 2024 to consider the following items: a) Sub-division/split of existing 1 (One) Equity Share of the face value of Rs. 10/- (Rupees Ten Only) each fully paid up into 5 (Five) Equity Shares of the face value of Rs. 2/- (Rupees Two Only) each fully paid up. b) Reclassification of the persons from the Promoter Group Category to the Public Category. The Board approved Re-classification of persons falling under Promoter Group and Sub-division/Stock Split of equity shares of the Company Approval of Board of Directors for Re-classification of Promoter Group to Public Category. (As Per BSE Announcement Dated on: 28/06/2024)
02-May-2024 16-May-2024 Accounts Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 inter alia to consider and approve the audited (Standalone & Consolidated) financial results of the company for the quarter and financial year ended March 31 2024. Results- Financial Results for the FY ended 31.3.2024 Re- appointment of Statutory Auditors (As per BSE Announcement Dated on 16/05/2024)
23-Jan-2024 03-Feb-2024 Quarterly Results Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results of the company for the quarter and nine months ended December 31 2023. Outcome of Board Meeting held on 3rd February, 2024 (As Per BSE Announcement Dated on: 03/02/2024)
28-Nov-2023 28-Nov-2023 Change in Directors Outcome of Board Meeting held on 28th November 2023 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Intimation of Change of Directors pursuant to Regulation 30 of SEBI LODR.
30-Oct-2023 07-Nov-2023 Quarterly Results Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results of the company for the quarter and half-year ended September 30 2023. Approval of unaudited Quarterly and financial results for the quarter and half yearly ended 30.09.2023. unaudited financial results for the quarter and Half Yearly ended 30.09.2023 Resignation of Mr. Shantanu Rastogi as Non-Executive & Non-Independent Director of the Company. (As Per BSE Announcement dated on 07.11.2023)
31-Jul-2023 07-Aug-2023 Quarterly Results Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 inter alia to consider and approve meeting of the Board of Directors of Krishna Institute of Medical Sciences Limited is scheduled to be held on Monday August 7 2023 inter alia to consider and approve the Unaudited (Standalone & Consolidated) Financial results of the company for the 1st quarter ended June 30 2023. Further to our intimations dated 31st July 2023, the Board of Directors, at its meeting held today, has approved the Un-Audited (Standalone and Consolidated) Financial Results of the Company for the 01st Quarter ended 30th June 2023 together with Limited Review Reports which has been reviewed by the Audit Committee and approved by the Board of Directors. Dr. B. Bhaskara Rao, Promoter & CMD has intimated to the Board that he has acquired 64.36% of the equity stake in M/s. Som Datt Finance Corporation Ltd, (Listed NBFC) and has been inducted into its Board as a Director. 1. Approval of unaudited financial Results for the Quarter ended 30.06.2023. 2. Dr. B Bhaskara Rao has intimated the Board that he has acquired 64.36% of Equity stake in Som Datt Finance Corporation Limited and has been inducted into its Board as Director. (As per BSE Announcement Dated on 07/08/2023)
26-Jul-2023 26-Jul-2023 Change in Other Executives Intimation of the Appointment of Mr. Sachin Ashok Salvi as Chief Financial Officer and KMP of the Company w.e.f August 01, 2023
11-May-2023 18-May-2023 Accounts Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2023 inter alia to consider and approve the Audited (Standalone & Consolidated) Financial results of the company for the quarter and financial year ended March 31 2023. Audited Results & Quarterly Results (As Per BSE Bulletin dated on 11.05.2023) 1. Approval of Audited standalone & Consolidated financial results of the Company for the quarter and year ended 31st March 2023, along with the Audit Report on the Standalone & Consolidated Financial Statements. 2. Resignation of CFO Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have approved the Audited Standalone and Consolidated Financial Results of the Company along with the Auditor's Report for the Quarter and Year ended 31st March 2023 issued by M/s. S.R. Batliboi & Associates LLP, the Statutory Auditors of the Company which are enclosed to this letter. The 21st Annual General Meeting of the Company will be held on Wednesday, 30th August 2023. (As per BSE Announcement Dated on 18/05/2023)
28-Jan-2023 09-Feb-2023 Quarterly Results Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve the Un-Audited (Standalone & Consolidated) Financial results of the company for the 3rd quarter and nine months ended December 31 2022 Further to our intimations dated 28th January 2023, the Board of Directors, at its meeting held today, has approved the Un-Audited Standalone and Consolidated Financial Results of the Company for the 3rd Quarter and nine months ended 31st December 2022 together with Limited Review Reports which have been reviewed by the Audit Committee and approved by the Board of Directors. (As Per BSE Announcement Dated on 09/02/2023)
31-Dec-2022 04-Jan-2023 Issue of Debentures Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/01/2023 inter alia to consider and approve A meeting of the Board of Directors of the Company is scheduled to be held on Wednesday January 4 2023 inter alia to consider and approve raising of funds by way of issuance of Non-Convertible Debentures (NCDs) aggregating to Rs. 300 Crores in one or more tranches over a period of time The Board of Directors, at its meeting held today, has inter alia, approved the raising of funds by way of issuance of Non-Convertible Debentures (NCDs) aggregating to Rs. 300 Crores in one or more tranches over a period of time, subject to shareholders approval. (As Per BSE Announcement Dated on 04.01.2023)
13-Dec-2022 12-Dec-2022 Change in Directors The appointment of Mr. Shantanu Girish Rastogi (DlN:06732021) as an Additional Director (Non-Executive Non-Independent) with effect from 10th December 2022 who will be liable to retire by rotation and holds office up to the ensuing Annual General Meeting. The said appointment has been recommended by the Nomination and Remuneration Committee earlier.
27-Oct-2022 11-Nov-2022 Quarterly Results Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve the Un-Audited (Standalone & Consolidated) Financial results of the company for the Quarter and Half Year ended September 30 2022. Krishna Institute of Medical Sciences Limited submits outcome of the Board Meeting held on 11th November, 2022 Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have approved the Un-Audited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the Quarter and Half Year ended 30th September, 2022 (As Per BSE Announcement dated on 11.11.2022) Pursuant to the provisions of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of newspaper advertisement of the unaudited standalone and consolidated financial results of the company for the Quarter and Half Year ended 30th September, 2022 published on 11th November, 2022 in Financial Express (English) and Navatelangana (Telugu). (As Per BSE Announcement Dated 12.11.2022)
02-Aug-2022 10-Aug-2022 Quarterly Results Quarterly Results Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 ,inter alia, to consider and approve meeting of the Board of Directors of the Company will be held on Wednesday, 10th August 2022 inter-alia to consider and approve, the standalone and consolidated un-audited financial results of the Company for the 1st quarter ended 30th June 2022. Krishna Institute of Medical Sciences Limited submits the Financials Results for the 01st Quarter ended 30th June, 2022. (As Per BSE Announcement dated on 10.08.2022)
1 2